The Claim
In older adults with preclinical Alzheimer’s disease, plasma phosphorylated tau 217 levels increase significantly over time before showing deceleration, with a 1.19 effect size at 36 months and a statistically significant deceleration (p<0.001), indicating that this biomarker reflects an early, dynamic phase of tau pathology that plateaus before widespread neurodegeneration.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In older adults with early-stage Alzheimer’s disease, levels of phosphorylated tau 217 in the blood rise steadily over time, slow down after 36 months, and this pattern corresponds to an early phase of tau protein changes that stabilize before extensive brain damage occurs.
See the scientific wording
In older adults with preclinical Alzheimer’s disease, plasma phosphorylated tau 217 levels increase significantly over time before showing deceleration, with a 1.19 effect size at 36 months and a statistically significant deceleration (p<0.001), suggesting it may reflect an early, dynamic phase of tau pathology that plateaus before widespread neurodegeneration.
Tau proteins inside brain cells become chemically modified and stick together, causing these clumps to grow over time. As the clumps get larger, they leak into the bloodstream, making the blood levels of this modified tau rise quickly. Once enough brain cells are affected, the rate of leakage slows down because the system reaches a limit in how much can escape.
What the research says
1 studyStudy: Concurrent changes in plasma p-tau217, tau PET, and cognition in preclinical Alzheimer’s disease
In older adults with early Alzheimer’s changes, a blood test for p-tau217 rises quickly over three years, then slows down — just like the claim says. This suggests it’s a good early warning sign of brain changes before serious memory problems start.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.